Skip to main content
Livermore
Livermore
ZHEN

Kiniksa Pharmaceuticals International, plc

KNSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001730430

In the last 90 days, Kiniksa Pharmaceuticals International, plc insiders filed 0 open-market purchases and 2 sales; 267 institutions reported holding it in 13F filings for Q2 2026, worth $2.99B in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding Kiniksa Pharmaceuticals International, plc changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of KNSA: Q4 2023 compared with Q1 2024
MeasureQ4 2023Of which not filed for Q1 2024Q1 2024Change
Holders1421154+13
Shares34.2M39.5K38.9M+4.75M (+13.9%)
Value$600.4M$692.6K$768.1M+$168.4M (+28.1%)

1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (33)

Institutions that held Kiniksa Pharmaceuticals International, plc at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to KNSA in Q1 2024
InstitutionSharesValue% of portfolio
HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse)3,135,735$61.9M1.34%
Braidwell LP1,392,716$27.5M0.89%
Peregrine Capital Management LLC236,045$4.66M0.13%
Knights of Columbus Asset Advisors LLC162,283$3.20M0.23%
Hussman Strategic Advisors, Inc.157,500$3.11M0.72%
Nordea Investment Management AB126,742$2.49M0.00%
Wellington Management Group LLP84,493$1.67M0.00%
SEI Investments Co73,481$1.45M0.00%
Dark Forest Capital Management LP70,596$1.39M0.24%
Brevan Howard Capital Management LP59,954$1.18M0.11%
Jackson Creek Investment Advisors LLC54,384$1.07M0.38%
Capula Management Ltd41,242$813.7K0.03%
Options Solutions, LLC40,205$793.2K0.45%
Voloridge Investment Management, LLC34,062$672.0K0.00%
Cerity Partners LLC29,683$585.6K0.00%
New York Life Investment Management LLC17,856$352.3K0.00%
HSBC Holdings PLC16,356$322.7K0.00%
Engineers Gate Manager LP14,934$294.6K0.01%
Mariner, LLC13,427$264.9K0.00%
Harbor Capital Advisors, Inc.13,142$259.0K0.03%
Bayesian Capital Management, LP11,245$221.9K0.02%
Algert Global LLC10,447$206.1K0.01%
State Board of Administration of Florida Retirement System13,467$144.9K0.00%
Caption Management, LLC6,000$118.4K0.01%
Simplex Trading, LLC5,049$99.0K0.00%
Lazard Asset Management LLC3,607$71.0K0.00%
Group One Trading, L.P.2,175$42.9K0.00%
Virtus Fund Advisers, LLC1,236$24.4K0.09%
Pacer Advisors, Inc.660$13.0K0.00%
National Bank of Canada500$9.76K0.00%
US Bancorp116$2.29K0.00%
Nelson, Van Denburg & Campbell Wealth Management Group, LLC34$6700.00%
Riggs Asset Managment Co. Inc.30$5920.00%

Sold out (20)

Institutions that held Kiniksa Pharmaceuticals International, plc at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of KNSA in Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
GMT Capital Corp341,553$5.99M
Walleye Capital LLC327,332$5.74M
Healthcare of Ontario Pension Plan Trust Fund227,500$3.99M
StemPoint Capital LP183,102$3.21M
Logos Global Management LP150,000$2.63M
ExodusPoint Capital Management, LP83,572$1.47M
HRT Financial LP74,866$1.31M
Ensign Peak Advisors, Inc66,443$1.17M
Advisory Research Inc65,450$1.15M
Opaleye Management Inc.37,500$640.2K
Point72 Middle East FZE24,218$424.8K
Walleye Trading LLC21,424$375.8K
Envestnet Asset Management Inc14,509$254.5K
Fox Run Management, L.L.C.12,546$220.1K
Y-Intercept (Hong Kong) Ltd12,180$213.6K
Dynamic Technology Lab Private Ltd12,160$213.0K
State of Wyoming2,342$41.1K
EntryPoint Capital, LLC1,743$30.6K
Newbridge Financial Services Group, Inc.300$5.26K
Planned Solutions, Inc.200$3.51K

Not filed for Q1 2024 yet (1)

Institutions that held Kiniksa Pharmaceuticals International, plc at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding KNSA in Q4 2023 that haven't filed for Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Putnam Investments LLC39,486$692.6K